Publications by authors named "Paula Haddock"

Claim this Profile
A
A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancers.
Charlotte Zoe Angel, Shannon Beattie, Ezanee Azlina Mohamad Hanif, Micheal P Ryan, Francisco D C Guerra Liberal, Paula Haddock

Cell Commun Signal· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer.
Ahmed Elkashif, Victoria Bingham, Paula Haddock, Matthew P Humphries, Stephen McQuaid

J Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer.
Catherine Knowlson, Paula Haddock, Victoria Bingham, Stephen McQuaid, Paul B Mullan

Ther Adv Med Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer.
Paul B Mullan, Victoria Bingham, Paula Haddock, Gareth W Irwin, Elaine Kay

BMC Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs).
Katy Orr, Niamh E Buckley, Paula Haddock, Colin James, Jean-Luc Parent

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer.
Niamh E Buckley, Paula Haddock, Ricardo De Matos Simoes, Eileen Parkes, Gareth Irwin

Oncotarget· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
Linda J Rennick, Rory D de Vries, Thomas J Carsillo, Ken Lemon, Geert van Amerongen, Paula Haddock

J Virol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis